Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
55,482,166
-
Total 13F shares
-
10,598,201
-
Share change
-
+539,119
-
Total reported value
-
$116,470,479
-
Price per share
-
$10.99
-
Number of holders
-
48
-
Value change
-
+$5,974,386
-
Number of buys
-
36
-
Number of sells
-
10
Institutional Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) as of Q2 2016
As of 30 Jun 2016,
Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) was held by
48 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,598,201 shares.
The largest 10 holders included
FMR LLC, BROOKSIDE CAPITAL MANAGEMENT LLC, Partner Fund Management, L.P., GOLDMAN SACHS GROUP INC, Casdin Capital, LLC, VANGUARD GROUP INC, BlackRock Fund Advisors, EVENTIDE ASSET MANAGEMENT, LLC, JPMORGAN CHASE & CO, and JANUS CAPITAL MANAGEMENT LLC.
This page lists
48
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.